eHealth (EHTH) 10-Q 10 Nov 14 2014 Q3 Quarterly report Financial data

Document_And_Entity_Informatio

Document And Entity Information	9 Months Ended
	Sep. 30, 2014	Nov. 01, 2014
Document And Entity Information [Abstract]	'	'
Document Type	'10-Q	'
Amendment Flag	'false	'
Document Period End Date	30-Sep-14	'
Document Fiscal Year Focus	'2014	'
Document Fiscal Period Focus	'Q3	'
Trading Symbol	'EHTH	'
Entity Registrant Name	'eHealth, Inc.	'
Entity Central Index Key	'0001333493	'
Current Fiscal Year End Date	'--12-31	'
Entity Filer Category	'Accelerated Filer	'
Entity Common Stock, Shares Outstanding	'	17,817,864

Condensed_Consolidated_Balance

Condensed Consolidated Balance Sheets (USD $)	Sep. 30, 2014		Dec. 31, 2013
In Thousands, unless otherwise specified
Current assets:	'		'
Cash and cash equivalents	$58,080		$107,055
Accounts receivable	5,878		4,586
Deferred income taxes	1,574		4,459
Prepaid expenses and other current assets	6,745		8,364
Total current assets	72,277		124,464
Property and equipment, net	10,526		10,283
Deferred income taxes	6,197		4,569
Other assets	6,019		5,518
Intangible assets, net	11,241		7,496
Goodwill	14,096		14,096
Total assets	120,356		166,426
Current liabilities:	'		'
Accounts payable	2,768		4,381
Accrued compensation and benefits	8,131		10,291
Accrued marketing expenses	2,464		8,227
Deferred revenue	2,267		1,784
Other current liabilities	2,846		2,561
Total current liabilities	18,476		27,244
Non-current liabilities	6,195		6,165
Stockholders’ equity:	'		'
Common stock	29		28
Additional paid-in capital	262,016		252,361
Treasury stock, at cost	-199,998	[1]	-149,998	[2]
Retained earnings	33,460		30,466
Accumulated other comprehensive income	178		160
Total stockholders’ equity	95,685		133,017
Total liabilities and stockholders’ equity	$120,356		$166,426
[1]	Cumulative balances at September 30, 2014 consist of shares repurchased in connection with our stock repurchase program announced on March 31, 2014, as well as previous stock repurchase plans announced in 2013, 2012, 2011, 2010 and 2008.
[2]	Cumulative balances at December 31, 2013 consist of shares repurchased in connection with our previous stock repurchase plans announced in 2013, 2012, 2011, 2010 and 2008.

Condensed_Consolidated_Stateme

Condensed Consolidated Statements Of Comprehensive Income (Loss) (USD $)	3 Months Ended		9 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Revenue	'	'	'	'
Commission	$36,164	$36,000	$120,267	$109,193
Other	5,004	6,008	14,435	15,822
Total revenue	41,168	42,008	134,702	125,015
Operating costs and expenses:	'	'	'	'
Cost of revenue	745	806	3,750	4,441
Marketing and advertising	9,228	14,852	41,946	43,448
Customer care and enrollment	9,695	8,936	28,392	23,914
Technology and content	10,303	9,117	30,320	23,585
General and administrative	7,077	7,540	22,228	22,191
Amortization of intangible assets	354	354	1,062	1,061
Total operating costs and expenses	37,402	41,605	127,698	118,640
Income from operations	3,766	403	7,004	6,375
Other expense, net	-13	-22	-81	-68
Income before provision for income taxes	3,753	381	6,923	6,307
Provision for income taxes	2,229	207	3,929	2,626
Net income	1,524	174	2,994	3,681
Foreign currency translation adjustment	1	-7	18	-25
Comprehensive income	$1,525	$167	$3,012	$3,656
Net income (loss) per share:	'	'	'	'
Basic (in usd per share)	$0.09	$0.01	$0.16	$0.19
Diluted (in usd per share)	$0.08	$0.01	$0.15	$0.18
Weighted Average Number of Shares Outstanding, Diluted [Abstract]	'	'	'	'
Basic (in shares)	17,836	18,436	18,551	19,310
Diluted (in shares)	18,394	19,096	19,341	19,912

Condensed_Consolidated_Stateme1

Condensed Consolidated Statements Of Cash Flows (USD $)	9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013
Operating activities	'	'
Net income	$2,994	$3,681
Adjustments to reconcile net income to net cash provided by operating activities:	'	'
Deferred income taxes	1,349	-3,951
Depreciation and amortization	3,111	2,290
Amortization of book-of-business consideration	1,909	2,822
Amortization of intangible assets	1,062	1,061
Stock-based compensation expense	6,585	5,361
Deferred rent	69	917
Changes in operating assets and liabilities:	'	'
Accounts receivable	-1,292	-2,131
Prepaid expenses and other assets	-1,072	-852
Accounts payable	-1,612	-1,895
Accrued compensation and benefits	-2,155	2,504
Accrued marketing expenses	-5,763	-196
Deferred revenue	420	3,794
Other current liabilities	254	1,370
Net cash provided by operating activities	5,859	14,775
Investing activities	'	'
Purchases of property and equipment	-3,335	-6,735
Purchase of intangible assets	-4,500	0
Net cash used in investing activities	-7,835	-6,735
Financing activities	'	'
Net proceeds from exercise of common stock options	3,902	4,650
Cash used to net-share settle equity awards	-3,506	-940
Excess tax benefits from stock-based compensation	2,648	4,217
Repurchase of common stock	-50,000	-59,007
Principal payments in connection with capital leases	-57	-41
Net cash used in financing activities	-47,013	-51,121
Effect of exchange rate changes on cash and cash equivalents	14	-17
Net decrease in cash and cash equivalents	-48,975	-43,098
Cash and cash equivalents at beginning of period	107,055	140,849
Cash and cash equivalents at end of period	$58,080	$97,751

Summary_Of_Business_And_Signif

Summary Of Business And Significant Accounting Policies	9 Months Ended
	Sep. 30, 2014
Accounting Policies [Abstract]	'
Summary Of Business And Significant Accounting Policies	'
	Note 1 - Summary of Business and Significant Accounting Policies
	Description of Business—eHealth, Inc. (the “Company,” “eHealth,” “we” or “us”) is the leading online source of health insurance for individuals, families and small businesses in the United States. Through our website addresses (www.eHealth.com,  www.eHealthInsurance.com,  www.eHealthMedicare.com, www.Medicare.com and www.PlanPrescriber.com), consumers can get quotes from leading health insurance carriers, compare plans side-by-side, and apply for and purchase individual and family, Medicare-related, small business and ancillary health insurance plans. We actively market the availability of Medicare-related insurance plans and offer Medicare plan comparison tools and educational materials for Medicare-related insurance plans, including Medicare Advantage, Medicare Supplement and Medicare Part D prescription drug plans.  Our ecommerce technology also enables us to deliver consumers’ health insurance applications electronically to health insurance carriers. As a result, we simplify and streamline the complex and traditionally paper-intensive health insurance sales and purchasing process. We are licensed to market and sell health insurance in all 50 states and the District of Columbia.
	Basis of Presentation—The accompanying condensed consolidated balance sheet as of September 30, 2014, the condensed consolidated statements of comprehensive income for the three and nine months ended September 30, 2013 and 2014 and the condensed consolidated statements of cash flows for the nine months ended September 30, 2013 and 2014, respectively, are unaudited. The condensed consolidated balance sheet data as of December 31, 2013 was derived from the audited consolidated financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2013, which was filed with the Securities and Exchange Commission on March 12, 2014. The accompanying statements should be read in conjunction with the audited consolidated financial statements and related notes contained in our Annual Report on Form 10-K.
	The accompanying condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles, or U.S. GAAP, for interim financial information. Accordingly, they do not include all of the financial information and footnotes required by U.S. GAAP for complete financial statements. The unaudited condensed consolidated financial statements have been prepared on the same basis as the audited consolidated financial statements in our Annual Report on Form 10-K for the year ended December 31, 2013, and include all adjustments necessary for the fair presentation of eHealth’s statement of financial position as of September 30, 2014, its results of operations for the three and nine months ended September 30, 2013 and 2014 and its cash flows for the nine months ended September 30, 2013 and 2014. All adjustments are of a normal recurring nature. The results for the three and nine months ended September 30, 2014 are not necessarily indicative of the results to be expected for any subsequent period or for the fiscal year ending December 31, 2014.
	Seasonality—In periods prior to the fourth quarter of 2013, the number of individual and family health insurance applications submitted through our ecommerce platform generally increased in our first quarter compared to our fourth quarter and in our third quarter compared to our second quarter. This trend changed in the fourth quarter of 2013 and the first quarter of 2014 as a result of an increase in the number of individual and family applications submitted during the initial open enrollment period, which began on October 1, 2013 and ended on March 31, 2014, as mandated by the federal Patient Protection and Affordable Care Act and related amendments in the Health Care and Education Reconciliation Act. Accordingly, the number of submitted individual and family plan applications, relative to historical levels, increased significantly during the fourth quarter of 2013 and the first quarter of 2014. Additionally, following completion of the initial open enrollment period, the number of submitted individual and family health insurance applications, relative to historical levels, decreased significantly during the second and third quarters of 2014, when only consumers with qualifying life events were able to purchase individual and family major medical plans.
	The majority of Medicare plans are sold in our fourth quarter during the Medicare annual enrollment period, when Medicare-eligible individuals are permitted to change their Medicare Advantage and Medicare Part D prescription drug coverage for the following year. As a result, we generate a significant amount of Medicare plan-related revenue in the fourth quarter of the year resulting from the sale of new Medicare plans. Additionally, we recognize a majority of our renewal Medicare Advantage and Medicare Part D prescription drug plan commission revenue in the first quarter of each year as the majority of policies sold during the annual enrollment period typically renew on January 1 of each year.
	Since a significant portion of our marketing and advertising expenses are driven by the number of health insurance applications submitted on our ecommerce platform, those expenses are influenced by seasonal submitted application patterns. As a result, in periods prior to the fourth quarter of 2013, marketing and advertising expenses related to individual and family health insurance plans have been highest in our first and third quarters, while marketing and advertising expenses related to Medicare-related plans have been highest in our third and fourth quarters. However, these historical trends were impacted by the initial open enrollment period for individual and family plans that began in October 2013 and ended on March 31, 2014. Marketing and advertising expenses increased significantly in the fourth quarter of 2013 and first quarter of 2014, relative to historical levels, and decreased significantly during the second and third quarters of 2014, consistent with the respective increases and decreases in submitted applications.
	As a result of our seasonal trends in years prior to 2013, our revenue was highest in the fourth quarter of the year and our profitability was highest in the first quarter. However, in connection with the initial open enrollment period for individual and family plans which began on October 1, 2013 and ended on March 31, 2014, as well as the Medicare annual enrollment period for Medicare plans in the fourth quarter of 2013, we experienced an increase in revenue in both the fourth quarter of 2013 and the first quarter of 2014 compared to the fourth quarter of 2012 and first quarter of 2013, respectively. However, given our significantly higher marketing and advertising expenses associated with the increase in the number of individual and family health insurance applications and Medicare related health insurance applications during the enrollment periods, we incurred a net loss in both the fourth quarter of 2013 and the first quarter of 2014. Conversely, in both the second and third quarters of 2014, we recorded net income due to significantly lower marketing and advertising expenses associated with the decrease in the number of individual and family health insurance applications outside of the open enrollment period.
	Recent Accounting Pronouncement—In May 2014, the FASB issued Accounting Standards Update No. 2014-09 (ASU 2014-09) “Revenue from Contracts with Customers.” ASU 2014-09 supersedes the revenue recognition requirements in “Revenue Recognition (Topic 605)”, and requires an entity to recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled to in exchange for those goods or services. ASU 2014-09 is effective for annual reporting periods beginning after December 15, 2016, including interim periods within that reporting period and can be adopted using either a full retrospective or modified retrospective approach. Early adoption is not permitted. We are currently in the process of evaluating the impact of the adoption of ASU 2014-09 on our consolidated financial statements.
	In August 2014, the FASB issued Accounting Standards Update No. 2014-15, (ASU 2015-15) “Going Concern.” ASU 2014-15 requires management of all entities to evaluate whether there are conditions and events that raise substantial doubt about the entity’s ability to continue as a going concern within one year after the financial statements are issued (or available to be issued when applicable). The guidance is effective for fiscal years beginning after December 15, 2016 and for interim periods within that fiscal year. We do not expect the adoption of this guidance to have a material effect on our consolidated financial statements.
	Recently Adopted Accounting Standards—Effective January 1, 2014, we adopted an accounting standards update with new guidance on the presentation of unrecognized tax benefits. This standard requires an entity to present an unrecognized tax benefit, or a portion of an unrecognized tax benefit, as a reduction to a deferred tax asset for a net operating loss carryforward, a similar tax loss, or a tax credit carryforward, except: to the extent a net operating loss carryforward, a similar tax loss, or a tax credit carryforward is not available at the reporting date under the tax law of the applicable jurisdiction to settle any additional income taxes that would result from the disallowance of a tax position or the tax law of the applicable jurisdiction does not require the entity to use, and the entity does not intend to use, the deferred tax asset for such purpose, the unrecognized tax benefit should be presented in the financial statements as a liability and should not be combined with deferred tax assets.  The adoption of this standard did not have a material effect on our condensed consolidated financial statements.
	Effective January 1, 2014, we adopted an accounting standards update with new guidance with respect to the release of cumulative translation adjustments into net income when a parent sells either a part or all of its investment in a foreign entity. This standard requires the release of cumulative translation adjustments when a company no longer holds a controlling financial interest in a subsidiary or group of assets that is a business within a foreign entity, and provides guidance for the acquisition in stages of a controlling interest in a foreign entity. The adoption of this standard did not have a material effect on our condensed consolidated financial statements.

Balance_Sheet_Accounts

Balance Sheet Accounts	9 Months Ended
	Sep. 30, 2014
Balance Sheet Related Disclosures [Abstract]	'
Balance Sheet Accounts	'
	Note 2 – Balance Sheet Accounts
	Cash and Cash Equivalents—As of December 31, 2013 and September 30, 2014, our cash equivalents consisted of money market accounts that invested in U.S. government-sponsored enterprise bonds and discount notes, U.S. government treasury bills and notes and repurchase agreements collateralized by U.S. government obligations. At December 31, 2013 and September 30, 2014, our cash equivalents carried no unrealized gains or losses and we did not realize any significant gains or losses on sales of cash equivalents during the three and nine months ended September 30, 2013 and 2014.
	As of December 31, 2013 and September 30, 2014, our cash and cash equivalent balances were invested as follows (in thousands):
		December 31, 2013		September 30, 2014
	Cash	$	16,935	$	21,459
	Money market funds	90,120		36,621
	Total cash and cash equivalents	$	107,055	$	58,080
	We used observable prices in active markets in determining the classification of our money market funds as Level 1 as of December 31, 2013 and September 30, 2014.
	Accounts Receivable—As of December 31, 2013 and September 30, 2014, our accounts receivable consisted of the following (in thousands):
		December 31, 2013		September 30, 2014
	Accounts receivable - from other revenues	$	2,322	$	2,270
	Commissions receivable	2,264		3,608
	Total accounts receivable	$	4,586	$	5,878
	Intangible Assets—On March 31, 2014, we purchased an internet domain name, www.Medicare.com, for $4.8 million. Cash consideration paid in connection with the purchase of the domain name totaled $4.5 million. The consideration paid also included $0.3 million of outstanding receivables from the owner of the domain name that were settled upon completion of the purchase. The related intangible asset was assigned an indefinite useful life. The carrying amounts, accumulated amortization, net carrying value and weighted average remaining life of our definite-lived amortizable intangible assets, as well as our indefinite-lived non-amortizable intangible trademarks and website addresses, are presented in the tables below (dollars in thousands, weighted-average useful life is as of September 30, 2014):
		December 31, 2013							September 30, 2014							Weighted Average Remaining Life
		Gross Carrying Amount					Net Carrying Amount		Gross Carrying Amount		Accumulated Amortization			Net Carrying Amount		30-Sep-14
				Accumulated Amortization
	Technology	$	1,752	$	(1,277	)	$	475	$	1,752	$	(1,536	)	$	216	0.6 years
	Pharmacy and customer relationships	10,410		(4,267		)	6,143		10,410		(5,001		)	5,409		5.5 years
	Trade names, trademarks and website addresses	907		(336		)	571		907		(405		)	502		5.6 years
	Total intangible	$	13,069	$	(5,880	)	7,189		$	13,069	$	(6,942	)	6,127
	assets subject
	to amortization
	Indefinite-lived trademarks and domain names						307							5,114		Indefinite
	Intangible						$	7,496						$	11,241
	assets
	During the three and nine months ended September 30, 2013, amortization expense related to intangible assets totaled $354,000 and $1,061,000, respectively. During the three and nine months ended September 30, 2014, amortization expense related to intangible assets totaled $354,000 and $1,062,000, respectively.
	As of September 30, 2014, expected amortization expense in future periods is as follows (in thousands):
	Years Ending December 31,	Technology		Pharmacy and Customer Relationships			Trade Names, Trademarks and Website Address		Total
	2014 (three months)	86		245			22		353
	2015	118		979			91		1,188
	2016	5		979			91		1,075
	2017	5		979			91		1,075
	2018	2		959			91		1,052
	Thereafter	-		1,268			116		1,384
	Total	$	216	$	5,409		$	502	$	6,127

Stockholders_Equity

Stockholders' Equity	9 Months Ended
	Sep. 30, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]	'
Stockholders' Equity	'
	Note 3 – Stockholders’ Equity
	Stock Plans—On June 12, 2014, upon approval at the Annual Meeting of Stockholders, we adopted the 2014 Equity Incentive Plan (the “2014 Plan”). The 2014 Plan replaced the 2006 Equity Incentive Plan and 4,500,000 shares were authorized for issuance under the 2014 Plan. The 2014 Plan does not include an evergreen provision to automatically increase the number of shares available under it and increases in the number of shares authorized for issuance under the 2014 Plan require stockholder approval. Also, under the 2014 Plan the following shares are not recycled for future grant under the 2014 Plan: (i) shares used in connection with the exercise of an option and/or stock appreciation right to pay the exercise price or purchase price of such award or satisfy applicable tax withholding obligations; and (ii) the gross number of shares subject to stock appreciation rights that are exercised. Furthermore, the 2014 Plan included a provision that prohibits repricing of outstanding stock options or stock appreciation rights and formalized and updated procedures to qualify awards as “performance-based” compensation under Section 162(m) of the Internal Revenue Code in order to preserve full tax deductibility of such awards.
	The following table summarizes activity under our 2014 Plan, 2006 Equity Incentive Plan, 1998 Stock Plan and 2005 Stock Plan (collectively, the “Stock Plans”) (in thousands):
		Shares Available for Grant
	Shares available for grant December 31, 2013	4,085
	Additional shares authorized (1)	751
	Restricted stock units granted	(462	)
	Options granted	(41	)
	Restricted stock units cancelled	14
	Options cancelled	16
	2014 Equity Incentive Plan adjustment (2)	(98	)
	Shares available for grant September 30, 2014	4,265
	-1	On January 1, 2014, the number of shares authorized for issuance under the 2006 Equity Incentive Plan was automatically increased pursuant to the terms of the 2006 Equity Incentive Plan.
	-2	On June 12, 2014, shares available for grant were adjusted to 4,500,000 pursuant to the terms of the 2014 Plan.
	We maintain our 2006 Equity Incentive Plan, 2005 Stock Plan and 1998 Stock Plan, under which we previously granted options to purchase shares of our common stock and restricted stock units. The 2006 Equity Incentive Plan was terminated with respect to the grant of additional awards on June 12, 2014, upon adoption of our 2014 Plan. The 2005 Stock Plan and 1998 Stock Plan were terminated with respect to the grant of additional awards upon the effectiveness of the 2006 Equity Incentive Plan. We will continue to issue new shares of common stock upon vesting of restricted stock units and the exercise of stock options previously granted under the 2006 Equity Incentive Plan, 2005 Stock Plan and 1998 Stock Plan.
	The following table summarizes stock option activity under the Stock Plans (in thousands, except per share amounts and weighted average remaining contractual life data):
		Number of Stock Options			Weighted Average Exercise Price				Weighted-Average Remaining Contractual Life (years)		Aggregate Intrinsic Value (1)
	Balance outstanding at December 31, 2013	1,979			$	17.91			4.2		$	56,569
	Granted	41			$	40.31
	Exercised	(243	)		$	16.02					$	6,350
	Cancelled	(34	)		$	26.99
	Balance outstanding at September 30, 2014	1,743			$	18.52			3.56		$	11,836
	Vested and expected to vest at September 30, 2014	1,694			$	18.38			3.52		$	11,612
	Exercisable at September 30, 2014	1,214			$	16.95			2.92		$	9,172
	-1	The aggregate intrinsic value is calculated as the difference between eHealth’s closing stock price as of December 31, 2013, the date of options exercised and September 30, 2014 and the exercise price of in-the-money options as of those dates.
	The total fair value of stock options vested during the three and nine months ended September 30, 2013 was $0.7 million and $2.6 million, respectively. The total fair value of stock options vested during the three and nine months ended September 30, 2014 was $0.7 million and $1.8 million, respectively.
	The following table summarizes restricted stock unit activity, including performance-based restricted stock unit activity, under the Stock Plans (in thousands, except weighted average remaining contractual life data):
		Number of Restricted Stock Units (1)			Weighted-Average Grant Date Fair Value				Weighted-Average Remaining Contractual Life (years)		Aggregate Intrinsic Value (2)
	Balance outstanding as of December 31, 2013	779			$	19.57			2.3		$	36,220
	Granted	462			$	40.72
	Vested	(218	)		$	19.51
	Cancelled	(19	)		$	28.13
	Balance outstanding as of September 30, 2014	1,004			$	29.16			2.31		$	24,223
	-1	Includes restricted stock units with both service and performance-based vesting criteria granted to our executive officers.
	-2	The aggregate intrinsic value is calculated as eHealth’s closing stock price as of December 31, 2013 and September 30, 2014 multiplied by the number of restricted stock units outstanding as of December 31, 2013 and September 30, 2014, respectively.
	The fair value of the restricted stock units is based on eHealth’s stock price on the date of grant, and compensation expense related to these awards is recognized on a straight-line basis over the vesting period. The fair value of performance-based restricted stock units is based on eHealth’s stock price on the date of grant, and compensation expense related to these awards is recognized on an accelerated basis over the vesting period. The amount of expense recorded for performance-based restricted stock units is based on expected attainment of performance criteria. The total fair value of restricted stock units vested during the three and nine months ended September 30, 2013 was $0.2 million and $3.5 million, respectively. The total fair value of restricted stock units vested during the three and nine months ended September 30, 2014 was $0.4 million and $10.3 million, respectively.
	Stock Repurchase Programs—On September 10, 2012, we announced that our board of directors approved a stock repurchase program authorizing us to purchase up to $30 million of our common stock and on March 6, 2013, we announced that our board of directors increased the approved repurchase amount under this program to $60 million. Purchases under this program were made in the open market. The cost of the repurchased shares was funded from available working capital. We completed repurchasing common stock under this program in June 2013 having repurchased 2,957,179 shares for $60.0 million at an average price of $20.29 per share.
	On March 31, 2014, we announced that our board of directors approved a stock repurchase program authorizing us to purchase up to $50 million of our common stock. Purchases under this program were made in the open market. We completed this stock repurchase program in July 2014 having repurchased in the aggregate 1.4 million shares for approximately $50.0 million at an average price of $36.91 per share including commissions. The cost of the repurchase was funded from available working capital.
	For accounting purposes, common stock repurchased under our stock repurchase programs is recorded based upon the settlement date of the applicable trade. Such repurchased shares are held in treasury and are presented using the cost method.
	Stock repurchase activity under our stock repurchase programs during the nine months ended September 30, 2014 is summarized as follows (dollar in thousands, except share and per share amounts):
		Total Number of Shares Repurchased			Average Price Paid Per Share (3)				Amount of Repurchase
	Cumulative balance at December 31, 2013 (1)	9,309,269			$	16.11			$	149,998
	Repurchases of common stock during 2014	1,354,619			$	36.91			$	50,000
	Cumulative balance at September 30, 2014 (2)	10,663,888			$	18.75			$	199,998
	-1	Cumulative balances at December 31, 2013 consist of shares repurchased in connection with our previous stock repurchase plans announced in 2013, 2012, 2011, 2010 and 2008.
	-2	Cumulative balances at September 30, 2014 consist of shares repurchased in connection with our stock repurchase program announced on March 31, 2014, as well as previous stock repurchase plans announced in 2013, 2012, 2011, 2010 and 2008.
	-3	Average price paid per share includes commissions.
	In addition to the shares repurchased under our repurchase programs as of September 30, 2014, we have in treasury 281,322 shares that were previously surrendered by employees to satisfy tax withholdings due in connection with the vesting of certain restricted stock units. As of December 31, 2013 and September 30, 2014, we had a total of 9,519,286 shares and 10,945,210 shares, respectively, held in treasury.
	Stock-Based Compensation—The fair value of stock options granted to employees for the three and nine months ended September 30, 2013 and 2014 was estimated using the following weighted average assumptions:
		Three Months Ended September 30,								Nine Months Ended September 30,
		2013				2014				2013			2014
	Expected term	4.3 years				4.2 years				4.3 years			4.2 years
	Expected volatility	39.8		%		46.9		%		39.7		%	46.3		%
	Expected dividend yield	—		%		—		%		—		%	—		%
	Risk-free interest rate	1.13		%		1.37		%		0.79		%	1.4		%
	Weighted-average fair value	$	8.39			$	13.09			$	7.02		$	15.5
	The following table summarizes stock-based compensation expense recorded during the three and nine months ended September 30, 2013 and 2014 (in thousands):
		Three Months Ended September 30,								Nine Months Ended September 30,
		2013				2014				2013			2014
	Common stock options	$	654			$	523			$	2,103		$	1,729
	Restricted stock units	1,291				1,767				3,258			4,856
	Total stock-based compensation expense	$	1,945			$	2,290			$	5,361		$	6,585
	The following table summarizes stock-based compensation expense by operating function for the three and nine months ended September 30, 2013 and 2014 (in thousands):
	Three Months Ended September 30,								Nine Months Ended September 30,
	2013				2014				2013			2014
Marketing and advertising	$	517			$	721			$	1,446		$	1,957
Customer care and enrollment	92				116				261			283
Technology and content	425				559				1,129			1,550
General and administrative	911				894				2,525			2,795
Total stock-based compensation expense	$	1,945			$	2,290			$	5,361		$	6,585

Income_Taxes

Income Taxes	9 Months Ended
	Sep. 30, 2014
Income Tax Disclosure [Abstract]	'
Income Taxes	'
	Note 4 – Income Taxes
	The following table summarizes our provision for income taxes and our effective tax rates for the three and nine months ended September 30, 2013 and 2014 (in thousands, except effective tax rate):
		Three Months Ended September 30,						Nine Months Ended September 30,
		2013			2014			2013			2014
	Income before provision for income taxes	$	381		$	3,753		$	6,307		$	6,923
	Provision for income taxes	$	207		$	2,229		$	2,626		$	3,929
	Effective tax rate	54.3		%	59.4		%	41.6		%	56.8		%
	Our effective tax rate in the three and nine months ended September 30, 2013 was higher than statutory federal and state tax rates due primarily to non-deductible lobbying expenses, partially offset by a tax benefit resulting from the extension of the federal research tax credit through December 31, 2013. Our effective tax rate in the three and nine months ended September 30, 2014 was higher than statutory federal and state tax rates due primarily to non-deductible lobbying expenses.
	During the three and nine months ended September 30, 2013, excess federal and state tax benefits related to share-based payments resulted in increases of $0.3 million and $4.2 million, respectively, in Additional Paid-In Capital in the condensed consolidated balance sheets. These amounts are also classified in the condensed consolidated statements of cash flows as both a reduction to operating cash flows and as a financing cash inflow. During the three and nine months ended September 30, 2014, excess federal and state tax benefits related to share-based payments resulted in a decrease of $1.0 million and an increase of $2.6 million, respectively, in Additional Paid-In Capital in the condensed consolidated balance sheets. These amounts are also classified in the condensed consolidated statements of cash flows as both a reduction to operating cash flows and as a financing cash inflow.

Net_Income_Per_Share

Net Income Per Share	9 Months Ended
	Sep. 30, 2014
Earnings Per Share [Abstract]	'
Net Income Per Share	'
	Net Income Per Share
	Basic net income per share is computed by dividing net income by the weighted-average number of common shares outstanding for the period. Diluted net income per share is computed by dividing the net income for the period by the weighted average number of common and common equivalent shares outstanding during the period. Diluted net income per share is computed giving effect to all potential dilutive common stock equivalent shares, including options and restricted stock units. The dilutive effect of outstanding awards is reflected in diluted net income per share by application of the treasury stock method.
	The following table sets forth the computation of basic and diluted net income per share (in thousands, except per share amounts):
		Three Months Ended September 30,						Nine Months Ended September 30,
		2013			2014			2013		2014
	Basic:
	Numerator:
	Net income allocated to common stock	$	174		$	1,524		$	3,681	$	2,994
	Denominator:
	Weighted average number of common stock shares outstanding	18,436			17,836			19,310		18,551
	Net income per share—basic:	$	0.01		$	0.09		$	0.19	$	0.16
	Diluted:
	Numerator:
	Net income allocated to common stock	$	174		$	1,524		$	3,681	$	2,994
	Denominator:
	Weighted average number of common stock shares outstanding	18,436			17,836			19,310		18,551
	Weighted average number of options	528			445			478		616
	Weighted average number of restricted stock units	132			113			124		174
	Total common stock shares used in diluted per share calculation	19,096			18,394			19,912		19,341
	Net income per share—diluted:	$	0.01		$	0.08		$	0.18	$	0.15
	For each of the three- and nine-month periods ended September 30, 2013 and 2014, we had securities outstanding that could potentially dilute net income per share, but the shares from the assumed exercise of these securities were excluded in the computation of diluted net income per share as their effect would have been anti-dilutive. The number of outstanding weighted average anti-dilutive shares that were excluded from the computation of diluted net income per share consisted of the following (in thousands):
		Three Months Ended September 30,					Nine Months Ended September 30,
		2013		2014			2013		2014
	Common stock options	127		219			439		127
	Restricted stock units	—		669			—		352
	Total	127		888			439		479

Geographic_Information_And_Sig

Geographic Information And Significant Customers	9 Months Ended
	Sep. 30, 2014
Segment Reporting [Abstract]	'
Geographic Information And Significant Customers	'
	Note 6 – Geographic Information and Significant Customers
	Geographic Information—As of December 31, 2013 and September 30, 2014, our long-lived assets consisted primarily of property and equipment, goodwill and other indefinite-lived intangible assets and finite-lived intangible assets. Our long-lived assets are attributed to the geographic location in which they are located. Long-lived assets by geographical area were as follows (in thousands):
		As of			As of
		December 31, 2013			September 30, 2014
	United States	$	37,046		$	41,427
	China	347			455
	Total	$	37,393		$	41,882
	Significant Customers—Substantially all revenue for the three and nine months ended September 30, 2013 and 2014 was generated from customers located in the United States. Carriers representing 10% or more of our total revenue in the three and nine months ended September 30, 2013 and 2014 are presented in the table below:
		Three Months Ended September 30,					Nine Months Ended September 30,
		2013		2014			2013		2014
	Humana	18	%	23	%		20	%	23	%
	WellPoint (1)	12	%	11	%		12	%	11	%
	UnitedHealthcare (2)	11	%	10	%		11	%	10	%
	Aetna (3)	10	%	9	%		9	%	10	%
	(1)Wellpoint also includes other carriers owned by Wellpoint.
	(2)UnitedHealthcare also includes other carriers owned by UnitedHealthcare.
	(3)Aetna also includes other carriers owned by Aetna.
	Commission revenue attributable to major medical individual and family health insurance plans was approximately 74% and 72% of our commission revenue in the three and nine months ended September 30, 2013, respectively. Commission revenue attributable to major medical individual and family health insurance plans was approximately 64% of our commission revenue in both the three and nine months ended September 30, 2014. We define our individual and family plan offerings as major medical individual and family health insurance plans, which do not include small business, Medicare-related health insurance plan offerings and other ancillary products such as short-term, stand-alone dental, life, vision, and accident insurance plan offerings.
	As of December 31, 2013, two customers represented 37% and 15%, respectively, of our $4.6 million outstanding accounts receivable balance. As of September 30, 2014, two customers represented 39% and 30% of our $5.9 million outstanding accounts receivable balance. No other customers represented 10% or more of our total accounts receivable at December 31, 2013 and September 30, 2014. We believe the potential for collection issues with any of our customers is minimal as of September 30, 2014. Accordingly, our estimate for uncollectible amounts at September 30, 2014 was not material.

Summary_Of_Business_And_Signif1

Summary Of Business And Significant Accounting Policies (Policy)	9 Months Ended
	Sep. 30, 2014
Accounting Policies [Abstract]	'
Description Of Business	'
	Description of Business—eHealth, Inc. (the “Company,” “eHealth,” “we” or “us”) is the leading online source of health insurance for individuals, families and small businesses in the United States. Through our website addresses (www.eHealth.com,  www.eHealthInsurance.com,  www.eHealthMedicare.com, www.Medicare.com and www.PlanPrescriber.com), consumers can get quotes from leading health insurance carriers, compare plans side-by-side, and apply for and purchase individual and family, Medicare-related, small business and ancillary health insurance plans. We actively market the availability of Medicare-related insurance plans and offer Medicare plan comparison tools and educational materials for Medicare-related insurance plans, including Medicare Advantage, Medicare Supplement and Medicare Part D prescription drug plans.  Our ecommerce technology also enables us to deliver consumers’ health insurance applications electronically to health insurance carriers. As a result, we simplify and streamline the complex and traditionally paper-intensive health insurance sales and purchasing process. We are licensed to market and sell health insurance in all 50 states and the District of Columbia.
Basis Of Presentation	'
	Basis of Presentation—The accompanying condensed consolidated balance sheet as of September 30, 2014, the condensed consolidated statements of comprehensive income for the three and nine months ended September 30, 2013 and 2014 and the condensed consolidated statements of cash flows for the nine months ended September 30, 2013 and 2014, respectively, are unaudited. The condensed consolidated balance sheet data as of December 31, 2013 was derived from the audited consolidated financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2013, which was filed with the Securities and Exchange Commission on March 12, 2014. The accompanying statements should be read in conjunction with the audited consolidated financial statements and related notes contained in our Annual Report on Form 10-K.
	The accompanying condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles, or U.S. GAAP, for interim financial information. Accordingly, they do not include all of the financial information and footnotes required by U.S. GAAP for complete financial statements. The unaudited condensed consolidated financial statements have been prepared on the same basis as the audited consolidated financial statements in our Annual Report on Form 10-K for the year ended December 31, 2013, and include all adjustments necessary for the fair presentation of eHealth’s statement of financial position as of September 30, 2014, its results of operations for the three and nine months ended September 30, 2013 and 2014 and its cash flows for the nine months ended September 30, 2013 and 2014. All adjustments are of a normal recurring nature. The results for the three and nine months ended September 30, 2014 are not necessarily indicative of the results to be expected for any subsequent period or for the fiscal year ending December 31, 2014.
Seasonality	'
	Seasonality—In periods prior to the fourth quarter of 2013, the number of individual and family health insurance applications submitted through our ecommerce platform generally increased in our first quarter compared to our fourth quarter and in our third quarter compared to our second quarter. This trend changed in the fourth quarter of 2013 and the first quarter of 2014 as a result of an increase in the number of individual and family applications submitted during the initial open enrollment period, which began on October 1, 2013 and ended on March 31, 2014, as mandated by the federal Patient Protection and Affordable Care Act and related amendments in the Health Care and Education Reconciliation Act. Accordingly, the number of submitted individual and family plan applications, relative to historical levels, increased significantly during the fourth quarter of 2013 and the first quarter of 2014. Additionally, following completion of the initial open enrollment period, the number of submitted individual and family health insurance applications, relative to historical levels, decreased significantly during the second and third quarters of 2014, when only consumers with qualifying life events were able to purchase individual and family major medical plans.
	The majority of Medicare plans are sold in our fourth quarter during the Medicare annual enrollment period, when Medicare-eligible individuals are permitted to change their Medicare Advantage and Medicare Part D prescription drug coverage for the following year. As a result, we generate a significant amount of Medicare plan-related revenue in the fourth quarter of the year resulting from the sale of new Medicare plans. Additionally, we recognize a majority of our renewal Medicare Advantage and Medicare Part D prescription drug plan commission revenue in the first quarter of each year as the majority of policies sold during the annual enrollment period typically renew on January 1 of each year.
	Since a significant portion of our marketing and advertising expenses are driven by the number of health insurance applications submitted on our ecommerce platform, those expenses are influenced by seasonal submitted application patterns. As a result, in periods prior to the fourth quarter of 2013, marketing and advertising expenses related to individual and family health insurance plans have been highest in our first and third quarters, while marketing and advertising expenses related to Medicare-related plans have been highest in our third and fourth quarters. However, these historical trends were impacted by the initial open enrollment period for individual and family plans that began in October 2013 and ended on March 31, 2014. Marketing and advertising expenses increased significantly in the fourth quarter of 2013 and first quarter of 2014, relative to historical levels, and decreased significantly during the second and third quarters of 2014, consistent with the respective increases and decreases in submitted applications.
	As a result of our seasonal trends in years prior to 2013, our revenue was highest in the fourth quarter of the year and our profitability was highest in the first quarter. However, in connection with the initial open enrollment period for individual and family plans which began on October 1, 2013 and ended on March 31, 2014, as well as the Medicare annual enrollment period for Medicare plans in the fourth quarter of 2013, we experienced an increase in revenue in both the fourth quarter of 2013 and the first quarter of 2014 compared to the fourth quarter of 2012 and first quarter of 2013, respectively. However, given our significantly higher marketing and advertising expenses associated with the increase in the number of individual and family health insurance applications and Medicare related health insurance applications during the enrollment periods, we incurred a net loss in both the fourth quarter of 2013 and the first quarter of 2014. Conversely, in both the second and third quarters of 2014, we recorded net income due to significantly lower marketing and advertising expenses associated with the decrease in the number of individual and family health insurance applications outside of the open enrollment period.
Recently Adopted Accounting Standards	'
	Recent Accounting Pronouncement—In May 2014, the FASB issued Accounting Standards Update No. 2014-09 (ASU 2014-09) “Revenue from Contracts with Customers.” ASU 2014-09 supersedes the revenue recognition requirements in “Revenue Recognition (Topic 605)”, and requires an entity to recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled to in exchange for those goods or services. ASU 2014-09 is effective for annual reporting periods beginning after December 15, 2016, including interim periods within that reporting period and can be adopted using either a full retrospective or modified retrospective approach. Early adoption is not permitted. We are currently in the process of evaluating the impact of the adoption of ASU 2014-09 on our consolidated financial statements.
	In August 2014, the FASB issued Accounting Standards Update No. 2014-15, (ASU 2015-15) “Going Concern.” ASU 2014-15 requires management of all entities to evaluate whether there are conditions and events that raise substantial doubt about the entity’s ability to continue as a going concern within one year after the financial statements are issued (or available to be issued when applicable). The guidance is effective for fiscal years beginning after December 15, 2016 and for interim periods within that fiscal year. We do not expect the adoption of this guidance to have a material effect on our consolidated financial statements.
	Recently Adopted Accounting Standards—Effective January 1, 2014, we adopted an accounting standards update with new guidance on the presentation of unrecognized tax benefits. This standard requires an entity to present an unrecognized tax benefit, or a portion of an unrecognized tax benefit, as a reduction to a deferred tax asset for a net operating loss carryforward, a similar tax loss, or a tax credit carryforward, except: to the extent a net operating loss carryforward, a similar tax loss, or a tax credit carryforward is not available at the reporting date under the tax law of the applicable jurisdiction to settle any additional income taxes that would result from the disallowance of a tax position or the tax law of the applicable jurisdiction does not require the entity to use, and the entity does not intend to use, the deferred tax asset for such purpose, the unrecognized tax benefit should be presented in the financial statements as a liability and should not be combined with deferred tax assets.  The adoption of this standard did not have a material effect on our condensed consolidated financial statements.
	Effective January 1, 2014, we adopted an accounting standards update with new guidance with respect to the release of cumulative translation adjustments into net income when a parent sells either a part or all of its investment in a foreign entity. This standard requires the release of cumulative translation adjustments when a company no longer holds a controlling financial interest in a subsidiary or group of assets that is a business within a foreign entity, and provides guidance for the acquisition in stages of a controlling interest in a foreign entity. The adoption of this standard did not have a material effect on our condensed consolidated financial statements.

Balance_Sheet_Accounts_Tables

Balance Sheet Accounts (Tables)	9 Months Ended
	Sep. 30, 2014
Balance Sheet Related Disclosures [Abstract]	'
Schedule Of Cash And Cash Equivalents	'
	As of December 31, 2013 and September 30, 2014, our cash and cash equivalent balances were invested as follows (in thousands):
		December 31, 2013		September 30, 2014
	Cash	$	16,935	$	21,459
	Money market funds	90,120		36,621
	Total cash and cash equivalents	$	107,055	$	58,080
Schedule Of Accounts Receivable	'
	Accounts Receivable—As of December 31, 2013 and September 30, 2014, our accounts receivable consisted of the following (in thousands):
		December 31, 2013		September 30, 2014
	Accounts receivable - from other revenues	$	2,322	$	2,270
	Commissions receivable	2,264		3,608
	Total accounts receivable	$	4,586	$	5,878
Schedule Of Intangible Assets	'
	The carrying amounts, accumulated amortization, net carrying value and weighted average remaining life of our definite-lived amortizable intangible assets, as well as our indefinite-lived non-amortizable intangible trademarks and website addresses, are presented in the tables below (dollars in thousands, weighted-average useful life is as of September 30, 2014):
		December 31, 2013							September 30, 2014							Weighted Average Remaining Life
		Gross Carrying Amount					Net Carrying Amount		Gross Carrying Amount		Accumulated Amortization			Net Carrying Amount		30-Sep-14
				Accumulated Amortization
	Technology	$	1,752	$	(1,277	)	$	475	$	1,752	$	(1,536	)	$	216	0.6 years
	Pharmacy and customer relationships	10,410		(4,267		)	6,143		10,410		(5,001		)	5,409		5.5 years
	Trade names, trademarks and website addresses	907		(336		)	571		907		(405		)	502		5.6 years
	Total intangible	$	13,069	$	(5,880	)	7,189		$	13,069	$	(6,942	)	6,127
	assets subject
	to amortization
	Indefinite-lived trademarks and domain names						307							5,114		Indefinite
	Intangible						$	7,496						$	11,241
	assets
Schedule Of Intangible Assets Future Amortization Expense	'
	As of September 30, 2014, expected amortization expense in future periods is as follows (in thousands):
	Years Ending December 31,	Technology		Pharmacy and Customer Relationships			Trade Names, Trademarks and Website Address		Total
	2014 (three months)	86		245			22		353
	2015	118		979			91		1,188
	2016	5		979			91		1,075
	2017	5		979			91		1,075
	2018	2		959			91		1,052
	Thereafter	-		1,268			116		1,384
	Total	$	216	$	5,409		$	502	$	6,127

Stockholders_Equity_Tables

Stockholders' Equity (Tables)	9 Months Ended
	Sep. 30, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]	'
Schedule Of Activity Under The Plans	'
	The following table summarizes activity under our 2014 Plan, 2006 Equity Incentive Plan, 1998 Stock Plan and 2005 Stock Plan (collectively, the “Stock Plans”) (in thousands):
		Shares Available for Grant
	Shares available for grant December 31, 2013	4,085
	Additional shares authorized (1)	751
	Restricted stock units granted	(462	)
	Options granted	(41	)
	Restricted stock units cancelled	14
	Options cancelled	16
	2014 Equity Incentive Plan adjustment (2)	(98	)
	Shares available for grant September 30, 2014	4,265
	-1	On January 1, 2014, the number of shares authorized for issuance under the 2006 Equity Incentive Plan was automatically increased pursuant to the terms of the 2006 Equity Incentive Plan.
	-2	On June 12, 2014, shares available for grant were adjusted to 4,500,000 pursuant to the terms of the 2014 Plan.
Schedule Of Stock Option Activity Under Stock Plans	'
	The following table summarizes stock option activity under the Stock Plans (in thousands, except per share amounts and weighted average remaining contractual life data):
		Number of Stock Options			Weighted Average Exercise Price				Weighted-Average Remaining Contractual Life (years)		Aggregate Intrinsic Value (1)
	Balance outstanding at December 31, 2013	1,979			$	17.91			4.2		$	56,569
	Granted	41			$	40.31
	Exercised	(243	)		$	16.02					$	6,350
	Cancelled	(34	)		$	26.99
	Balance outstanding at September 30, 2014	1,743			$	18.52			3.56		$	11,836
	Vested and expected to vest at September 30, 2014	1,694			$	18.38			3.52		$	11,612
	Exercisable at September 30, 2014	1,214			$	16.95			2.92		$	9,172
	-1	The aggregate intrinsic value is calculated as the difference between eHealth’s closing stock price as of December 31, 2013, the date of options exercised and September 30, 2014 and the exercise price of in-the-money options as of those dates.
Schedule Of Restricted Stock Unit Activity Under Stock Plans	'
	The following table summarizes restricted stock unit activity, including performance-based restricted stock unit activity, under the Stock Plans (in thousands, except weighted average remaining contractual life data):
		Number of Restricted Stock Units (1)			Weighted-Average Grant Date Fair Value				Weighted-Average Remaining Contractual Life (years)		Aggregate Intrinsic Value (2)
	Balance outstanding as of December 31, 2013	779			$	19.57			2.3		$	36,220
	Granted	462			$	40.72
	Vested	(218	)		$	19.51
	Cancelled	(19	)		$	28.13
	Balance outstanding as of September 30, 2014	1,004			$	29.16			2.31		$	24,223
	-1	Includes restricted stock units with both service and performance-based vesting criteria granted to our executive officers.
	-2	The aggregate intrinsic value is calculated as eHealth’s closing stock price as of December 31, 2013 and September 30, 2014 multiplied by the number of restricted stock units outstanding as of December 31, 2013 and September 30, 2014, respectively.
Schedule of Stock Repurchase Activity	'
	Stock repurchase activity under our stock repurchase programs during the nine months ended September 30, 2014 is summarized as follows (dollar in thousands, except share and per share amounts):
		Total Number of Shares Repurchased			Average Price Paid Per Share (3)				Amount of Repurchase
	Cumulative balance at December 31, 2013 (1)	9,309,269			$	16.11			$	149,998
	Repurchases of common stock during 2014	1,354,619			$	36.91			$	50,000
	Cumulative balance at September 30, 2014 (2)	10,663,888			$	18.75			$	199,998
	-1	Cumulative balances at December 31, 2013 consist of shares repurchased in connection with our previous stock repurchase plans announced in 2013, 2012, 2011, 2010 and 2008.
	-2	Cumulative balances at September 30, 2014 consist of shares repurchased in connection with our stock repurchase program announced on March 31, 2014, as well as previous stock repurchase plans announced in 2013, 2012, 2011, 2010 and 2008.
	-3	Average price paid per share includes commissions.
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions	'
	The fair value of stock options granted to employees for the three and nine months ended September 30, 2013 and 2014 was estimated using the following weighted average assumptions:
		Three Months Ended September 30,								Nine Months Ended September 30,
		2013				2014				2013			2014
	Expected term	4.3 years				4.2 years				4.3 years			4.2 years
	Expected volatility	39.8		%		46.9		%		39.7		%	46.3		%
	Expected dividend yield	—		%		—		%		—		%	—		%
	Risk-free interest rate	1.13		%		1.37		%		0.79		%	1.4		%
	Weighted-average fair value	$	8.39			$	13.09			$	7.02		$	15.5
Schedule Of Stock-Based Compensation Expense	'
	The following table summarizes stock-based compensation expense recorded during the three and nine months ended September 30, 2013 and 2014 (in thousands):
		Three Months Ended September 30,								Nine Months Ended September 30,
		2013				2014				2013			2014
	Common stock options	$	654			$	523			$	2,103		$	1,729
	Restricted stock units	1,291				1,767				3,258			4,856
	Total stock-based compensation expense	$	1,945			$	2,290			$	5,361		$	6,585
	The following table summarizes stock-based compensation expense by operating function for the three and nine months ended September 30, 2013 and 2014 (in thousands):
		Three Months Ended September 30,								Nine Months Ended September 30,
		2013				2014				2013			2014
	Marketing and advertising	$	517			$	721			$	1,446		$	1,957
	Customer care and enrollment	92				116				261			283
	Technology and content	425				559				1,129			1,550
	General and administrative	911				894				2,525			2,795
	Total stock-based compensation expense	$	1,945			$	2,290			$	5,361		$	6,585

Income_Taxes_Tables

Income Taxes (Tables)	9 Months Ended
	Sep. 30, 2014
Income Tax Disclosure [Abstract]	'
Summary Of Provision (Benefit) For Income Taxes And Effective Tax Rate	'
	The following table summarizes our provision for income taxes and our effective tax rates for the three and nine months ended September 30, 2013 and 2014 (in thousands, except effective tax rate):
		Three Months Ended September 30,						Nine Months Ended September 30,
		2013			2014			2013			2014
	Income before provision for income taxes	$	381		$	3,753		$	6,307		$	6,923
	Provision for income taxes	$	207		$	2,229		$	2,626		$	3,929
	Effective tax rate	54.3		%	59.4		%	41.6		%	56.8		%

Net_Income_Per_Share_Tables

Net Income Per Share (Tables)	9 Months Ended
	Sep. 30, 2014
Earnings Per Share [Abstract]	'
Schedule Of Computation Of Basic And Diluted Net Income (Loss) Per Share	'
	The following table sets forth the computation of basic and diluted net income per share (in thousands, except per share amounts):
		Three Months Ended September 30,						Nine Months Ended September 30,
		2013			2014			2013		2014
	Basic:
	Numerator:
	Net income allocated to common stock	$	174		$	1,524		$	3,681	$	2,994
	Denominator:
	Weighted average number of common stock shares outstanding	18,436			17,836			19,310		18,551
	Net income per share—basic:	$	0.01		$	0.09		$	0.19	$	0.16
	Diluted:
	Numerator:
	Net income allocated to common stock	$	174		$	1,524		$	3,681	$	2,994
	Denominator:
	Weighted average number of common stock shares outstanding	18,436			17,836			19,310		18,551
	Weighted average number of options	528			445			478		616
	Weighted average number of restricted stock units	132			113			124		174
	Total common stock shares used in diluted per share calculation	19,096			18,394			19,912		19,341
	Net income per share—diluted:	$	0.01		$	0.08		$	0.18	$	0.15
Schedule Of Anti-dilutive Shares Excluded From Computation Of Net Income (Loss) Per Share	'
	The number of outstanding weighted average anti-dilutive shares that were excluded from the computation of diluted net income per share consisted of the following (in thousands):
		Three Months Ended September 30,					Nine Months Ended September 30,
		2013		2014			2013		2014
	Common stock options	127		219			439		127
	Restricted stock units	—		669			—		352
	Total	127		888			439		479

Geographic_Information_And_Sig1

Geographic Information And Significant Customers (Tables)	9 Months Ended
	Sep. 30, 2014
Segment Reporting [Abstract]	'
Schedule Of Long Lived Assets By Geographical Areas	'
	Long-lived assets by geographical area were as follows (in thousands):
		As of			As of
		December 31, 2013			September 30, 2014
	United States	$	37,046		$	41,427
	China	347			455
	Total	$	37,393		$	41,882
Schedule Of Revenue By Major Customers	'
	Carriers representing 10% or more of our total revenue in the three and nine months ended September 30, 2013 and 2014 are presented in the table below:
		Three Months Ended September 30,					Nine Months Ended September 30,
		2013		2014			2013		2014
	Humana	18	%	23	%		20	%	23	%
	WellPoint (1)	12	%	11	%		12	%	11	%
	UnitedHealthcare (2)	11	%	10	%		11	%	10	%
	Aetna (3)	10	%	9	%		9	%	10	%
	(1)Wellpoint also includes other carriers owned by Wellpoint.
	(2)UnitedHealthcare also includes other carriers owned by UnitedHealthcare.
	(3)Aetna also includes other carriers owned by Aetna.

Recovered_Sheet1

Summary of Business And Significant Accounting Policies (Narrative) (Details)	Sep. 30, 2014
	state
Accounting Policies [Abstract]	'
Number of states in which the Company is licensed to market and sell health insurance	50

Balance_Sheet_Accounts_Narrati

Balance Sheet Accounts (Narrative) (Details) (USD $)	0 Months Ended	3 Months Ended		9 Months Ended
	Mar. 31, 2014	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013	Mar. 31, 2014
Balance Sheet Related Disclosures [Abstract]	'	'	'	'	'	'
Acquired indefinite-lived intangible assets	$4,800,000	'	'	'	'	'
Cash paid for intangible assets acquired	4,500,000	'	'	4,500,000	0	'
Outstanding receivables	'	'	'	'	'	300,000
Amortization of Intangible Assets	'	$354,000	$354,000	$1,062,000	$1,061,000	'

Balance_Sheet_Accounts_Schedul

Balance Sheet Accounts (Schedule Of Cash And Cash Equivalents) (Details) (USD $)	Sep. 30, 2014	Dec. 31, 2013	Sep. 30, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified
Cash and Cash Equivalents, at Carrying Value [Abstract]	'	'	'	'
Cash	$21,459	$16,935	'	'
Cash Equivalents, at Carrying Value	36,621	90,120	'	'
Total Cash and Cash Equivalents	$58,080	$107,055	$97,751	$140,849

Balance_Sheet_Accounts_Schedul1

Balance Sheet Accounts (Schedule Of Accounts Receivable) (Details) (USD $)	Sep. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Accounts Receivable, Net [Abstract]	'	'
Accounts receivable - from other revenues	$2,270	$2,322
Commissions receivable	3,608	2,264
Total accounts receivable	$5,878	$4,586

Balance_Sheet_Accounts_Schedul2

Balance Sheet Accounts (Schedule Of Intangible Assets) (Details) (USD $)	9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Dec. 31, 2013
Schedule Of Intangible Assets [Line Items]	'	'
Gross Carrying Amount	$13,069	$13,069
Accumulated Amortization	-6,942	-5,880
Total finite-lived intangible assets, net	6,127	7,189
Intangible assets	11,241	7,496
Technology [Member]	'	'
Schedule Of Intangible Assets [Line Items]	'	'
Gross Carrying Amount	1,752	1,752
Accumulated Amortization	-1,536	-1,277
Total finite-lived intangible assets, net	216	475
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life	'0 years 7 months 15 days	'
Pharmacy And Customer Relationships [Member]	'	'
Schedule Of Intangible Assets [Line Items]	'	'
Gross Carrying Amount	10,410	10,410
Accumulated Amortization	-5,001	-4,267
Total finite-lived intangible assets, net	5,409	6,143
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life	'5 years 6 months 8 days	'
Trade Names, Trademarks and Website Addresses [Member]	'	'
Schedule Of Intangible Assets [Line Items]	'	'
Gross Carrying Amount	907	907
Accumulated Amortization	-405	-336
Total finite-lived intangible assets, net	502	571
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life	'5 years 7 months 0 days	'
Indefinite-Lived Trademarks And Domain Names [Member]	'	'
Schedule Of Intangible Assets [Line Items]	'	'
Indefinite-Lived Intangible Assets (Excluding Goodwill)	$5,114	$307

Balance_Sheet_Accounts_Schedul3

Balance Sheet Accounts (Schedule Of Intangible Asset Future Amortization Expense) (Details) (USD $)	Sep. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Finite-Lived Intangible Assets [Line Items]	'	'
2014 (three months)	$353	'
2015	1,188	'
2016	1,075	'
2017	1,075	'
2018	1,052	'
Thereafter	1,384	'
Total finite-lived intangible assets, net	6,127	7,189
Technology [Member]	'	'
Finite-Lived Intangible Assets [Line Items]	'	'
2014 (three months)	86	'
2015	118	'
2016	5	'
2017	5	'
2018	2	'
Total finite-lived intangible assets, net	216	475
Pharmacy And Customer Relationships [Member]	'	'
Finite-Lived Intangible Assets [Line Items]	'	'
2014 (three months)	245	'
2015	979	'
2016	979	'
2017	979	'
2018	959	'
Thereafter	1,268	'
Total finite-lived intangible assets, net	5,409	6,143
Trade Names, Trademarks and Website Addresses [Member]	'	'
Finite-Lived Intangible Assets [Line Items]	'	'
2014 (three months)	22	'
2015	91	'
2016	91	'
2017	91	'
2018	91	'
Thereafter	116	'
Total finite-lived intangible assets, net	$502	$571

Stockholders_Equity_Narrative_

Stockholders' Equity (Narrative) (Details) (USD $)	0 Months Ended	3 Months Ended		9 Months Ended			12 Months Ended
	Sep. 10, 2012	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014		Sep. 30, 2013	Dec. 31, 2013	Jun. 12, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]	'	'	'	'		'	'	'
Shares available for grant under 2014 Plan	'	4,265,000	'	4,265,000		'	4,085,000	4,500,000
Total grant date fair value of stock options vested	'	$700,000	$700,000	$1,800,000		$2,600,000	'	'
Total fair value of restricted stock units vested	'	400,000	200,000	10,300,000		3,500,000	'	'
Stock repurchase program, authorized amount	30,000,000	'	'	50,000,000		'	60,000,000	'
Repurchase of common stock, shares	'	'	'	1,354,619		'	2,957,179	'
Repurchase of common stock	'	'	'	$50,000,000		'	$60,000,000	'
Average price per share of stock repurchased under stock repurchase program	'	'	'	$36.91	[1]	'	$20.29	'
Treasury shares held to satisfy tax withholdings	'	281,322	'	281,322		'	'	'
Treasury stock number of shares held	'	10,945,210	'	10,945,210		'	9,519,286	'
[1]	Average price paid per share includes commissions.

Stockholders_Equity_Schedule_O

Stockholders' Equity (Schedule Of Activity Under The Plans) (Details)	9 Months Ended
	Sep. 30, 2014		Jun. 12, 2014
Statement of Stockholders' Equity [Abstract]	'		'
Shares available for grant, beginning balance	4,085,000		4,500,000
Additional shares authorized	751,000	[1]	'
Restricted stock units granted	-462,000		'
Options granted	-41,000		'
Restricted stock units cancelled	14,000		'
Options cancelled	16,000		'
2014 Equity Incentive Plan adjustment	-98,000	[2]	'
Shares available for grant, ending balance	4,265,000		4,500,000
[1]	On January 1, 2014, the number of shares authorized for issuance under the 2006 Equity Incentive Plan was automatically increased pursuant to the terms of the 2006 Equity Incentive Plan.
[2]	On June 12, 2014, shares available for grant were adjusted to 4,500,000 pursuant to the terms of the 2014 Plan.

Stockholders_Equity_Schedule_O1

Stockholders' Equity (Schedule Of Option Activity Under Stock Plans) (Details) (USD $)	9 Months Ended		12 Months Ended
In Thousands, except Share data, unless otherwise specified	Sep. 30, 2014		Dec. 31, 2013
Number of Stock Options	'		'
Granted	41,000		'
Cancelled	-16,000		'
Common Stock Options [Member]	'		'
Number of Stock Options	'		'
Balance outstanding at December 31, 2013	1,979,000		'
Granted	41,000		'
Exercised	-243,000		'
Cancelled	-34,000		'
Balance outstanding at September 30, 2014	1,743,000		1,979,000
Number of Stock Options Vested and expected to vest at June 30, 2014	1,694,000		'
Number of Stock Options Exercisable at June 30, 2014	1,214,000		'
Weighted-Average Exercise Price, balance outstanding at December 31, 2013	$17.91		'
Weighted-Average Exercise Price, Granted	$0		'
Weighted-Average Exercise Price, Exercised	$16.02		'
Weighted-Average Exercise Price, Cancelled	$26.99		'
Weighted-Average Exercise Price, Balance outstanding at June 30, 2014	$18.52		$17.91
Weighted-Average Exercise Price, Vested and expected to vest at June 30, 2014	$18.38		'
Weighted-Average Exercise Price, Exercisable at June 30, 2014	$16.95		'
Weighted-Average Remaining Contractual Life (years), Balance outstanding at December 31, 2013	'3 years 6 months 21 days		'4 years 2 months 12 days
Weighted-Average Remaining Contractual Life (years), Balance outstanding at June 30, 2014	'3 years 6 months 21 days		'4 years 2 months 12 days
Weighted-Average Remaining Contractual Life (years), Vested and expected to vest at June 30, 2014	'3 years 6 months 8 days		'
Weighted-Average Remaining Contractual Life (years), Exercisable at June 30, 2014	'2 years 11 months 1 day		'
Aggregate Intrinsic Value, Balance outstanding at December 31, 2013	$56,569	[1]	'
Aggregate Intrinsic Value, Exercised	6,350	[1]	'
Aggregate Intrinsic Value, Balance outstanding at June 30, 2014	11,836	[1]	56,569	[1]
Aggregate Intrinsic Value, Vested and expected to vest at June 30, 2014	11,612	[1]	'
Aggregate Intrinsic Value, Exercisable at June 30, 2014	$9,172	[1]	'
[1]	The aggregate intrinsic value is calculated as the difference between eHealth’s closing stock price as of December 31, 2013, the date of options exercised and September 30, 2014 and the exercise price of in-the-money options as of those dates.

Stockholders_Equity_Schedule_O2

Stockholders' Equity (Schedule Of Restricted Stock Unit Activity Under Stock Plans) (Details) (USD $)	9 Months Ended		12 Months Ended
In Thousands, except Share data, unless otherwise specified	Sep. 30, 2014		Dec. 31, 2013
Number of Restricted Stock Units	'		'
Granted	462,000		'
Cancelled	-14,000		'
Restricted Stock [Member]	'		'
Number of Restricted Stock Units	'		'
Balance outstanding as of December 31, 2013	779,000	[1]	'
Granted	462,000	[1]	'
Vested	-218,000	[1]	'
Cancelled	-19,000	[1]	'
Balance outstanding as of September 30, 2014	1,004,000	[1]	779,000	[1]
Weighted-Average Grant Date Fair Value, Balance outstanding as of December 31, 2013	$19.57		'
Weighted-Average Grant Date Fair Value, Granted	$40.72		'
Weighted-Average Grant Date Fair Value, Vested	$19.51		'
Weighted-Average Grant Date Fair Value, Cancelled	$28.13		'
Weighted-Average Grant Date Fair Value, Balance outstanding as of June 30, 2014	$29.16		$19.57
Weighted-Average Remaining Contractual Life (years), Balance outstanding as of December 31, 2013	'2 years 3 months 22 days		'2 years 3 months 18 days
Weighted-Average Remaining Contractual Life (years), Balance outstanding as of June 30, 2014	'2 years 3 months 22 days		'2 years 3 months 18 days
Aggregate Intrinsic Value, Balance outstanding as of December 31, 2013	$36,220	[2]	'
Aggregate Intrinsic Value, Balance outstanding as of June 30, 2014	$24,223	[2]	$36,220	[2]
[1]	Includes restricted stock units with both service and performance-based vesting criteria granted to our executive officers.
[2]	The aggregate intrinsic value is calculated as eHealth’s closing stock price as of December 31, 2013 and September 30, 2014 multiplied by the number of restricted stock units outstanding as of December 31, 2013 and September 30, 2014, respectively.

Recovered_Sheet2

Stockholders' Equity (Schedule of Stock Repurchase Activity Under Stock Repurchase Programs) (Details) (USD $)	9 Months Ended		12 Months Ended
In Thousands, except Share data, unless otherwise specified	Sep. 30, 2014		Dec. 31, 2013
Total Number of Shares Repurchased	'		'
Cumulative balance at December 31, 2013 (1)	9,309,269	[1]	'
Repurchases of common stock during 2014	1,354,619		2,957,179
Cumulative balance at September 30, 2014 (2)	10,663,888	[2]	9,309,269	[1]
Average Price Paid Per Share	'		'
Cumulative balance at December 31, 2013 (1)	$16.11	[1],[3]	'
Repurchases of common stock during 2014	$36.91	[3]	$20.29
Cumulative balance at September 30, 2014 (2)	$18.75	[2],[3]	$16.11	[1],[3]
Amount of Repurchase	'		'
Cumulative balance at December 31, 2013 (1)	$149,998	[1]	'
Repurchases of common stock during 2014	50,000		60,000
Cumulative balance at September 30, 2014 (2)	$199,998	[2]	$149,998	[1]
[1]	Cumulative balances at December 31, 2013 consist of shares repurchased in connection with our previous stock repurchase plans announced in 2013, 2012, 2011, 2010 and 2008.
[2]	Cumulative balances at September 30, 2014 consist of shares repurchased in connection with our stock repurchase program announced on March 31, 2014, as well as previous stock repurchase plans announced in 2013, 2012, 2011, 2010 and 2008.
[3]	Average price paid per share includes commissions.

Recovered_Sheet3

Stockholders' Equity (Schedule of Fair Value of Stock Options, Valuation Assumptions) (Details) (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Equity [Abstract]	'	'	'	'
Expected term	'4 years 2 months 12 days	'4 years 3 months 18 days	'4 years 2 months 12 days	'4 years 3 months 18 days
Expected volatility	46.90%	39.80%	46.30%	39.70%
Expected dividend yield	0.00%	0.00%	0.00%	0.00%
Risk-free interest rate	1.37%	1.13%	1.40%	0.79%
Weighted-average fair value	$13.09	$8.39	$15.50	$7.02

Stockholders_Equity_Schedule_O3

Stockholders' Equity (Schedule Of Stock-Based Compensation Expense) (Details) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]	'	'	'	'
Common stock options	$523	$654	$1,729	$2,103
Restricted stock units	1,767	1,291	4,856	3,258
Total stock-based compensation expense	$2,290	$1,945	$6,585	$5,361

Stockholders_Equity_Schedule_O4

Stockholders' Equity (Schedule Of Stock-Based Compensation Expense By Operating Function) (Details) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Component Of Stock Based Compensation Expense [Line Items]	'	'	'	'
Total Stock-Based Compensation Expense	$2,290	$1,945	$6,585	$5,361
Marketing and Advertising Expense [Member]	'	'	'	'
Component Of Stock Based Compensation Expense [Line Items]	'	'	'	'
Total Stock-Based Compensation Expense	721	517	1,957	1,446
Customer Care And Enrollment Expense [Member]	'	'	'	'
Component Of Stock Based Compensation Expense [Line Items]	'	'	'	'
Total Stock-Based Compensation Expense	116	92	283	261
Technology And Content Expense [Member]	'	'	'	'
Component Of Stock Based Compensation Expense [Line Items]	'	'	'	'
Total Stock-Based Compensation Expense	559	425	1,550	1,129
General and Administrative Expense [Member]	'	'	'	'
Component Of Stock Based Compensation Expense [Line Items]	'	'	'	'
Total Stock-Based Compensation Expense	$894	$911	$2,795	$2,525

Income_Taxes_Details

Income Taxes (Details) (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Income Tax Disclosure [Abstract]	'	'	'	'
Income (loss) before provision (benefit) for income taxes	$3,753,000	$381,000	$6,923,000	$6,307,000
Income Tax Expense (Benefit)	2,229,000	207,000	3,929,000	2,626,000
Effective tax rate	59.40%	54.30%	56.80%	41.60%
Increase in additional paid-in capital related to excess federal and state tax benefits	$1,000,000	$300,000	$2,600,000	$4,200,000

Net_Income_Per_Share_Schedule_

Net Income Per Share (Schedule Oof Computation Of Basic And Diluted Net Income (Loss) Per Share) (Details) (USD $)	3 Months Ended		9 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Earnings Per Share [Abstract]	'	'	'	'
Net income (loss) allocated to common stock	$1,524	$174	$2,994	$3,681
Net weighted average number of common stock shares outstanding	17,836	18,436	18,551	19,310
Net income (loss) per share-basic	$0.09	$0.01	$0.16	$0.19
Weighted average number of options	445	528	616	478
Weighted average number of restricted stock units	113	132	174	124
Total common stock shares used in per share calculation	18,394	19,096	19,341	19,912
Net income (loss) per share-diluted	$0.08	$0.01	$0.15	$0.18

Net_Income_Per_Share_Schedule_1

Net Income Per Share (Schedule Of Anti-Dilutive Shares Excluded From Computation Of Net Income Per Share) (Details)	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]	'	'	'	'
Total	888,000	127,000	479,000	439,000
Common Stock Options [Member]	'	'	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]	'	'	'	'
Total	219,000	127,000	127,000	439,000
Restricted Stock Units [Member]	'	'	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]	'	'	'	'
Total	669,000	0	352,000	0

Geographic_Information_And_Sig2

Geographic Information And Significant Customers (Details) (USD $)

Sep. 30, 2014

Dec. 31, 2013

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Dec. 31, 2013

Sep. 30, 2014

Dec. 31, 2013

Sep. 30, 2014

Dec. 31, 2013

In Thousands, unless otherwise specified

Commission Revenue [Member]

Commission Revenue [Member]

Commission Revenue [Member]

Commission Revenue [Member]

Accounts Receivable [Member]

Accounts Receivable [Member]

Accounts Receivable [Member]

Accounts Receivable [Member]

Accounts Receivable [Member]

Accounts Receivable [Member]

Major Medical Individual And Family Insurance Plans [Member]

Major Medical Individual And Family Insurance Plans [Member]

Major Medical Individual And Family Insurance Plans [Member]

Major Medical Individual And Family Insurance Plans [Member]

Customer Concentration Risk [Member]

Customer Concentration Risk [Member]

Customer One [Member]

Customer One [Member]

Customer Two [Member]

Customer Two [Member]

customer

customer

Concentration Risk [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

Number of significant customers

'

'

'

'

'

'

2

2

'

'

'

'

Concentration risk, percentage

'

'

64.00%

74.00%

64.00%

72.00%

'

'

39.00%

37.00%

30.00%

15.00%

Accounts receivable

$5,878

$4,586

'

'

'

'

'

'

'

'

'

'

Geographic_Information_And_Sig3

Geographic Information And Significant Customers (Schedule Of Long Lived Assets By Geographical Areas) (Details) (USD $)	Sep. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Long-lived assets	$41,882	$37,393
UNITED STATES	'	'
Long-lived assets	41,427	37,046
CHINA	'	'
Long-lived assets	$455	$347

Geographic_Information_And_Sig4

Geographic Information And Significant Customers (Schedule Of Revenue By Major Customers) (Details)

3 Months Ended

9 Months Ended

3 Months Ended

9 Months Ended

3 Months Ended

9 Months Ended

3 Months Ended

9 Months Ended

3 Months Ended

9 Months Ended

3 Months Ended

9 Months Ended

3 Months Ended

9 Months Ended

3 Months Ended

9 Months Ended

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2013

Humana [Member]

Humana [Member]

WellPoint [Member]

WellPoint [Member]

UnitedHealthcare [Member]

UnitedHealthcare [Member]

Aetna [Member]

Aetna [Member]

Sales [Member]

Sales [Member]

Sales [Member]

Sales [Member]

Sales [Member]

Sales [Member]

Sales [Member]

Sales [Member]

Humana [Member]

Humana [Member]

WellPoint [Member]

WellPoint [Member]

UnitedHealthcare [Member]

UnitedHealthcare [Member]

Aetna [Member]

Aetna [Member]

Revenue, Major Customer [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Concentration risk, percentage

23.00%

23.00%

11.00%

[1]

11.00%

[1]

10.00%

[2]

10.00%

[2]

9.00%

[3]

10.00%

[3]

18.00%

20.00%

12.00%

[1]

12.00%

[1]

11.00%

[2]

11.00%

[2]

10.00%

[3]

9.00%

[3]

[1]

Wellpoint also includes other carriers owned by Wellpoint.

[2]

UnitedHealthcare also includes other carriers owned by UnitedHealthcare.

[3]

Aetna also includes other carriers owned by Aetna.